BDBM700399 US20240336610, Example 5::US20240336610, GDI-005

SMILES CC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(C#N)c1cncc(C)c1)C2(C)C)C(C)(C)C

InChI Key InChIKey=VSYBQRYMLSUHEC-UHFFFAOYSA-N

Data  1 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 700399   

TargetReplicase polyprotein 1a(2019-nCoV)
The Global Health Drug Discovery Institute

US Patent
LigandPNGBDBM700399(US20240336610, Example 5 | US20240336610, GDI-005)
Affinity DataIC50: 80nMAssay Description:An inhibition test was conducted using 200 nM recombinant SARS-CoV-2 main protease and 15 μM fluorescent substrate (Dabcyl-TSAVL QSGFRK-Glu (EDA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
The Global Health Drug Discovery Institute

US Patent
LigandPNGBDBM700399(US20240336610, Example 5 | US20240336610, GDI-005)
Affinity DataEC50:  117nMAssay Description:An inhibition test was conducted using 200 nM recombinant SARS-CoV-2 main protease and 15 μM fluorescent substrate (Dabcyl-TSAVL QSGFRK-Glu (EDA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent